Report Detail
Global (United States, European Union and China) Anti-depressant Drugs Market Research Report 2019-2025
- RnM3670322 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
In 2019, the market size of Anti-depressant Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-depressant Drugs.
This report studies the global market size of Anti-depressant Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-depressant Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
ALKERMES PLC
ALLERGAN PLC
BRISTOL MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
GLAXOSMITHKLINE INC.
H. LUNDBECK A/S
MERCK INC.
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL INC.
Market Segment by Product Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market Segment by Application
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-depressant Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-depressant Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-depressant Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tricyclic Antidepressants
- 1.3.3 Selective Serotonin Reuptake Inhibitors
- 1.3.4 Serotonin-Norepinephrine Reuptake Inhibitors
- 1.3.5 Monoamine Oxidase Inhibitors
- 1.3.6 Serotonin Antagonist
- 1.3.7 Reuptake Inhibitors
- 1.3.8 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Anti-depressant Drugs Market Share by Application (2019-2025)
- 1.4.2 Major Depressive Disorder
- 1.4.3 Obsessive-Compulsive Disorder
- 1.4.4 Generalized Anxiety Disorder
- 1.4.5 Panic Disorder
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti-depressant Drugs Market Size
- 2.1.1 Global Anti-depressant Drugs Revenue 2014-2025
- 2.1.2 Global Anti-depressant Drugs Sales 2014-2025
- 2.2 Anti-depressant Drugs Growth Rate by Regions
- 2.2.1 Global Anti-depressant Drugs Sales by Regions 2014-2019
- 2.2.2 Global Anti-depressant Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti-depressant Drugs Sales by Manufacturers
- 3.1.1 Anti-depressant Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Anti-depressant Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti-depressant Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti-depressant Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti-depressant Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti-depressant Drugs Price by Manufacturers
- 3.4 Key Manufacturers Anti-depressant Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti-depressant Drugs Market
- 3.6 Key Manufacturers Anti-depressant Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Tricyclic Antidepressants Sales and Revenue (2014-2019)
- 4.1.2 Selective Serotonin Reuptake Inhibitors Sales and Revenue (2014-2019)
- 4.1.3 Serotonin-Norepinephrine Reuptake Inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Monoamine Oxidase Inhibitors Sales and Revenue (2014-2019)
- 4.1.5 Serotonin Antagonist Sales and Revenue (2014-2019)
- 4.1.6 Reuptake Inhibitors Sales and Revenue (2014-2019)
- 4.1.7 Others Sales and Revenue (2014-2019)
- 4.2 Global Anti-depressant Drugs Sales Market Share by Type
- 4.3 Global Anti-depressant Drugs Revenue Market Share by Type
- 4.4 Anti-depressant Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti-depressant Drugs Sales by Application
6 United States
- 6.1 United States Anti-depressant Drugs Breakdown Data by Company
- 6.2 United States Anti-depressant Drugs Breakdown Data by Type
- 6.3 United States Anti-depressant Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Anti-depressant Drugs Breakdown Data by Company
- 7.2 European Union Anti-depressant Drugs Breakdown Data by Type
- 7.3 European Union Anti-depressant Drugs Breakdown Data by Application
8 China
- 8.1 China Anti-depressant Drugs Breakdown Data by Company
- 8.2 China Anti-depressant Drugs Breakdown Data by Type
- 8.3 China Anti-depressant Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti-depressant Drugs Breakdown Data by Company
- 9.2 Rest of World Anti-depressant Drugs Breakdown Data by Type
- 9.3 Rest of World Anti-depressant Drugs Breakdown Data by Application
- 9.4 Rest of World Anti-depressant Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Anti-depressant Drugs Sales by Countries
- 9.4.2 Rest of World Anti-depressant Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 ALKERMES PLC
- 10.1.1 ALKERMES PLC Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.1.4 Anti-depressant Drugs Product Introduction
- 10.1.5 ALKERMES PLC Recent Development
- 10.2 ALLERGAN PLC
- 10.2.1 ALLERGAN PLC Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.2.4 Anti-depressant Drugs Product Introduction
- 10.2.5 ALLERGAN PLC Recent Development
- 10.3 BRISTOL MYERS SQUIBB COMPANY
- 10.3.1 BRISTOL MYERS SQUIBB COMPANY Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.3.4 Anti-depressant Drugs Product Introduction
- 10.3.5 BRISTOL MYERS SQUIBB COMPANY Recent Development
- 10.4 ELI LILLY AND COMPANY
- 10.4.1 ELI LILLY AND COMPANY Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.4.4 Anti-depressant Drugs Product Introduction
- 10.4.5 ELI LILLY AND COMPANY Recent Development
- 10.5 GLAXOSMITHKLINE INC.
- 10.5.1 GLAXOSMITHKLINE INC. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.5.4 Anti-depressant Drugs Product Introduction
- 10.5.5 GLAXOSMITHKLINE INC. Recent Development
- 10.6 H. LUNDBECK A/S
- 10.6.1 H. LUNDBECK A/S Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.6.4 Anti-depressant Drugs Product Introduction
- 10.6.5 H. LUNDBECK A/S Recent Development
- 10.7 MERCK INC.
- 10.7.1 MERCK INC. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.7.4 Anti-depressant Drugs Product Introduction
- 10.7.5 MERCK INC. Recent Development
- 10.8 PFIZER INC.
- 10.8.1 PFIZER INC. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.8.4 Anti-depressant Drugs Product Introduction
- 10.8.5 PFIZER INC. Recent Development
- 10.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
- 10.9.1 TEVA PHARMACEUTICAL INDUSTRIES LTD. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.9.4 Anti-depressant Drugs Product Introduction
- 10.9.5 TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent Development
- 10.10 TAKEDA PHARMACEUTICAL INC.
- 10.10.1 TAKEDA PHARMACEUTICAL INC. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Anti-depressant Drugs
- 10.10.4 Anti-depressant Drugs Product Introduction
- 10.10.5 TAKEDA PHARMACEUTICAL INC. Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti-depressant Drugs Sales Channels
- 11.2.2 Anti-depressant Drugs Distributors
- 11.3 Anti-depressant Drugs Customers
12 Market Forecast
- 12.1 Global Anti-depressant Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti-depressant Drugs Sales Forecast by Type
- 12.3 Global Anti-depressant Drugs Sales Forecast by Application
- 12.4 Anti-depressant Drugs Forecast by Regions
- 12.4.1 Global Anti-depressant Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti-depressant Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti-depressant Drugs. Industry analysis & Market Report on Anti-depressant Drugs is a syndicated market report, published as Global (United States, European Union and China) Anti-depressant Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti-depressant Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
